SEC Company Response from ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — Jul 11, 2018
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: July 11, 2018 · CIK: 0001174940 · Accession: 0001193125-18-215934
AI Filing Summary & Sentiment
File numbers found in text: 333-224950
Show Raw Text
CORRESP 1 filename1.htm CORRESP Oragenics, Inc. 4902 Eisenhower Boulevard, Suite Tampa, Florida 33634 July 11, 2018 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Healthcare and Insurance 100 F Street, N.E. Washington, D.C. 20549-3628 Attn: Ms. Dorrie Yale Re: Oragenics, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-224950 Request for Acceleration Dear Ms. Yale: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above referenced Registration Statement on Form S-1 be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on Thursday July 12, 2018, or as soon thereafter as is practicable. Please call Mark Catchur, of Shumaker, Loop & Kendrick, LLP counsel to the Registrant, at (813) 227-2264 with any comments or questions regarding this matter. Very truly yours, By: /s/ Michael Sullivan Name: Michael Sullivan Title: Chief Financial Officer cc: Mark A. Catchur, Shumaker, Loop & Kendrick, LLP